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Synthesis of L-Cys(NHCH 3 )
Cysteine N-methyl amide was prepared in two steps from Boc-L-Cys(Trt)-OH. In the first step, 1 g of Boc-L-Cys(Trt)-OH (2.16 mmol), 364 mg of HOBt•H2O (2.38 mmol), and 455mg of EDC•HCl (2.38 mmol) were dissolved in 35mL of DCM. The mixture was stirred under argon on ice until almost everything dissolved. 3.25 mL of 2 M methylamine in THF (6.48 mmol) was added, followed by 3 mL of DMF to help solubilize whatever was still left in solution. Finally, 413 µL of DIPEA were added to neutralize any excess HCl from the EDC. The reaction was warmed up to room temperature and stirred overnight. The next day, the solution was extracted with two 25 mL 5% citric acid washes, one water wash, then two 25 mL saturated bicarbonate washes. The organic phase was collected and dried by rotary evaporation. In the second step, 40 mL of deprotection cocktail (49:50:1 of DCM:TFA:TIS) was added to dissolve the residue, and the deprotection was carried out for 30 minutes at room temperature.
The solvent was removed under vacuum, and the residue was resuspended in 20 mL of water then filtered. The filtrate was collected and analyzed by Ellman's test to determine free thiol concentration, indicating a 74% yield. The solution was frozen and lyophilized to give an amorphous solid, which was
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analyzed by 1 H-NMR to confirm the product ( Figure S3A ). The product was dissolved in water and stored at -80 °C.
Solution-phase synthesis of CF(OCH 3 ) and CF(NH 2 )
Boc-L-Cys(Trt) (0.575 mmol, 267 mg), HOBT (0.575 mmol, 78 mg), and EDC•HCl (0.575 mmol, 110 mg) were dissolved in DCM (9 mL) in a 25-mL flask under argon atmosphere at 0 °C.
DIPEA (0.575 mmol, 100 µL) was added to the mixture slowly and it was stirred for 15 min at 0 °C.
Then phenylalanine methyl ester HCl (0.46 mmol, 100 mg) was dissolved in 1mL of DMF and added to the mixture, followed by more DIPEA (0.575 mmol, 100 µL). After 20 minutes, the reaction was allowed to proceed overnight under argon and warm slowly to room temperature as the ice melted. The next morning, 25mL of ether was added to the reaction solution, and the solution was transferred to a separatory funnel. The reaction solution was extracted twice with 25 mL of 5% citric acid, then twice with 25 mL of saturated sodium bicarbonate. The organic phase was removed leaving a damp precipitate which was redissolved in 20 mL of DCM. 20 mL of TFA and 500 µL of TIS were added and the deprotection was carried out for 30 minutes. The DCM/TFA was rotovapped off, then the precipitated material was resuspended in 25mL of aqueous 0.1% TFA and filtered. The dissolved crude dipeptide was purified by preparative RP-HPLC over a 10-25% B gradient in 60 minutes, preceded by a 5 minute isocratic phase in 10% B. The pure HPLC fractions were lyophilized then redissolved in water. The concentration was determined by Ellman's test and by phenylalanine absorbance at 257 nm (ε 257 = 190 1/M*cm), then the peptide was diluted to 100 mM and stored at -80 °C. The CF(NH 2 ) peptide was prepared analogously to the CF(OCH 3 ) peptide, with isolated yields of 55% and 50%, respectively. The products were confirmed by 1 H-NMR (Figures S3B-C) and by ESI-MS (Table S1 ).
Solid-phase synthesis of CFN(NH 2 ), CFA(NH 2 ), and CAN(NH 2 )
Fmoc-based solid phase peptide synthesis (SPPS) using standard Fmoc amino acids was used to produce the three C-extein tripeptides. The peptides were synthesized on Rink amide resin at a 0.25 mmol scale as follows. First, 20% piperidine in DMF was used for Fmoc deprotection of the resin using a one minute equilibration of the resin followed by a 20 minute incubation at room temperature with agitation by a stream of N 2 gas. After Fmoc deprotection and DMF washes, amino acids were coupled using HOBt/HBTU as activating agents. First, the amino acid (1.25 mmol) was dissolved to 0.5 M in a DMF solution containing 0.45 M HOBt and 0.45 M HBTU (2.5 mL). DIPEA (2.5 mmol) was added to the amino acid/activating agent solution, and the mixture was immediately added to the resin. The coupling reaction was carried out for 30 minutes at room temperature with agitation by a stream of N 2 gas. After substantial washing with DMF, subsequent deprotections and couplings were carried out identically as the initial steps.
The peptides were cleaved off the resin using 95% TFA, 2.5% TIS and 2.5% H 2 O (4 mL) for two hours at room temperature. After cleavage, the crude peptides were precipitated with 45 mL of cold diethyl ether. The precipitates were redissolved in water with 0.1 % TFA and purified by preparative RP-HPLC on C 18 prep column over a 0-15% B gradient in 60 minutes. The purified peptides were analyzed by analytical RP-HPLC, 1 H-NMR ( Figures S3D-F) and ESI-MS (Table S1 ) to confirm their identity and purity. Peptide concentrations were determined by the Ellman's test for free thiols and phenylalanine absorbance when applicable.
Cloning of N-and C-intein plasmids
The N-inteins were cloned into a pET vector with a His 6 -SUMO tag at the 5' end of the multiple cloning site by overlap-extension PCR. The C1A mutation (red and underlined) was introduced into this plasmid using the QuikChange SiteDirected Mutagenesis kit with the manufacturer's recommended protocol.
The C-inteins were also cloned by overlap-extension PCR 1 into a modified pTXB1 intein vector containing the GyrA intein mutated for EPL followed by a C-terminal His 6 -tag. First, the NpuC and SspC genes were amplified from previously used expression vectors 2 with the appropriate overhangs.
Then the resulting amplicons were inserted upstream of GyrA in the pTXB1 vector to yield the plasmids pTXB1-NpuC-GyrA-H 6 and pTXB1-SspC-GyrA-H 6 , which encode for the following protein sequences:
The D124Y, H125N, and N137A mutations (red and underlined) were introduced into this plasmid using the QuikChange Site-Directed Mutagenesis kit with the manufacturer's recommended protocol.
* Note that for the SspC fusion, the N-terminal methionine (italics and underlined) was removed >50% by endogenous methionine amino-peptidases when over-expressed in E. coli BL21(DE3) cells, whereas for NpuC it is only cleaved roughly 10-20%. 
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peptide. These one-pot thiolysis/ligation reaction solutions were kept at room temperature for [15] [16] [17] [18] [19] [20] hours. For both reaction types, if the pH dropped after addition of all reagents, it was raised to pH 7.5 by addition of sodium hydroxide. Note that if the MESNa thiolysis and ligation reaction were not done in one pot, the C-terminal asparagine thioester would cyclize, then hydrolyze, resulting in a dead-end side product carboxylic acid.
After analysis by analytical RP-HPLC to confirm reaction completion, HPLC solvent B was added to achieve a final concentration of 10% B. Then, neat TFA was added to 0.5% to acidify the solution. Upon acidification, the cleaved GyrA-H 6 protein typically precipitated, but no C-intein adduct was lost. This solution was centrifuged then filtered for purification by preparative RP-HPLC. All Cintein constructs (typically 20-30 mL) were loaded on a C 18 preparative column over a 10 minute isocratic phase in 10% B. Then the system was raised to the gradient starting conditions (20% or 25% B) over a 5 minute phase. Finally, the proteins were purified over a 20-35% B or 25-40% B gradient in 60 minutes. Fractions were analyzed by analytical RP-HPLC, and the purest fractions were lyophilized, then redissolved in water and pooled. Concentrations (50-400 µM) were determined by A 280 using a calculated extinction coefficient (ProtParam tool on the Expasy server). 3 Purity of the constructs was assessed by analytical RP-HPLC ( Figure S7 ), and their identities were confirmed by ESI-MS (Table S2) .
Purification of N-intein constructs
E. coli BL21(DE3) cells transformed with each N-intein plasmid were grown in 2 L of LB containing 50 µg/mL of kanamycin at 37°C until OD 600 = 0.6. The cells were then cooled down to 18 °C, and expression was induced by addition of 0.5 mM IPTG for 16 hours at 18 °C. After harvesting the cells by centrifugation (10,500 rcf, 30 min), the cell pellets were transferred to 50 mL conical tubes with 5 mL of lysis buffer (50 mM phosphate, 300 mM NaCl, 5 mM imidazole, 2 mM BME, pH 8.0) and stored at -80°C. The cell pellets were resuspended by adding an additional 35 mL of lysis buffer supplemented with Complete protease inhibitor cocktail. Cells were lysed by sonication (35% S10 amplitude, 10x 20 second pulses separated by 30 seconds on ice). The soluble fraction was recovered by centrifugation (35,000 rcf, 30 min). The soluble fraction was mixed with 4 mL of Ni-NTA resin and incubated at 4°C for 30 minutes. After incubation, the slurry was loaded onto a fritted column. After discarding the flow-through, the column was washed with 5 column volumes (CV) of lysis buffer, 5 CV of wash buffer 1 (lysis buffer with 20 mM imidazole), and 3 CV of wash buffer 2 (lysis buffer with 50 mM imidazole). The protein was eluted with elution buffer (lysis buffer with 250 mM imidazole) in four 1.5 CV elution fractions. The wash and elution fractions were analyzed by SDS-PAGE on Mini-PROTEN TGX gels run in Tris/glycine/SDS running buffer ( Figure S5A ). The purest fractions of eluted protein were dialyzed at 4 °C against lysis buffer to remove excess imidazole.
As an alternative, cleaner and higher-yielding enrichment method, the N-intein could be extracted from the insoluble E. coli inclusion bodies as follows. First, the lysate pellet was resuspended in 40 mL of Triton wash buffer (lysis buffer with 0.1% Triton X-100) and incubated at room temperature for 30 minutes. The Triton wash was centrifuged at 35,000 rcf for 30 minutes, and the supernatant was discarded. Next, the pellet was resuspended in 40 mL of lysis buffer containing 6 M urea, and the mixture was incubated overnight at 4°C. The mixture was centrifuged at 35,000 rcf for 30 minutes, and then the supernatant was mixed with 4 mL of NiNTA resin. The Ni column was run identically as for the native purifications described above, except that every buffer had a background of 6 M urea ( Figure S5B) . Following enrichment over a Ni-NTA column, the protein was refolded into lysis buffer (without urea) by step-wise dialysis removal of the urea and excess imidazole at 4°C. It is noteworthy that the flow-through from this denaturing Ni column could be reapplied to Ni resin to purify even more of the desired protein.
After enrichment over the Ni-NTA columns, the native or refolded proteins were treated with 10 mM TCEP and Ulp1 (SUMO-specific protease) overnight at room temperature. The cleavage was confirmed by RP-HPLC/MS, after which the reaction solution was incubated with Ni-NTA resin at room temperature for 30 min. The flow-through and two 1.5 CV washes with wash buffer 1 were S11 collected and pooled ( Figure S6) . The protein was then concentrated to 10 mL, treated with 10 mM TCEP, injected onto the S75 16/60 gel filtration column, and eluted over 1.35 CV in freshly prepared, degassed splicing assay buffer (100 mM sodium phosphate, 150 mM NaCl, 1 mM EDTA, pH 7.2)
supplemented with 1mM DTT. FPLC fractions were analyzed by SDS-PAGE, and the purest fractions were pooled and analyzed by analytical RP-HPLC ( Figure S7 ) and ESI-MS (Table S2 ). The concentration of pure protein was determined by UV A 280nm using the calculated extinction coefficient. 3 The N-inteins could be stored at -80 °C after adding buffered glycerol to a final concentration of 20%
and flash-freezing in liquid N 2 .
RP-HPLC and ESI-MS analysis of protein trans-splicing
Prior to any splicing assay, the N-intein solutions were dialyzed against splicing assay buffer (100 mM sodium phosphates, 150 mM NaCl, 1 mM EDTA, pH 7.2) containing no thiols overnight at 4°C. If thiols were present, substantial N-extein cleavage could be observed for reactions with a slow k 3 , however 1 mM DTT had no impact on reactions with k 3 > 1.5 x 10 -3 s -1
. Note that for reaction 15, even in the absence of thiols, some N-extein cleavage was observed due to the extremely slow k 3 (see Figure   S12 . N-extein cleavage is characterized by a re-emergence of the starting material, species 1). After removing thiols, N-inteins were diluted to 15 µM in assay buffer, C-inteins were diluted to 10 µM, and both solutions were treated with 2 mM TCEP. The solutions were incubated at 30 °C for 10 minutes, For RP-HPLC analysis, reactions were typically carried out on a 1.3-1.4 mL scale, where 100 µL were removed at each time point and mixed with 33 µL of quenching solution. 100 µL of the quenched solutions were separated 0-73% B gradient in 30 minutes on a C 18 analytical column, recording absorbance at 214 nm ( Figure S9 ). The major peaks were collected and identified by ESI-MS (Table S3 ) The complex mixture of multiply-charged states of each species were deconvoluted using the Maximum Entropy algorithm (Spectrum Square Associates, Ithaca, NY) into spectra depicting a well-defined mixture of singly-charged species ( Figure S10 and Table S3 ).
Kinetic analysis of trans-splicing reactions
The RP-HPLC and ESI-MS data were quantified to yield reaction progress curves. First, using the manufacturer's analytical software, the peak areas for all relevant chromatographic or mass spectrometric peaks were calculated. For RP-HPLC, the relevant peaks came from species 1-5, and for ESI-MS, the relevant peaks came from species 1-4 ( Figure S8 ). Then, for each time point in a reaction, the area of an individual peak was expressed as a fraction of the total peak area. Reaction progress curves for each species were generated by expressing this normalized intensity as a function of time ( Figures S11 and S12 ). Note that species 3-5 are all products that irreversibly form after branched intermediate resolution (Figures 1 and S1 ). Since 3 and 5 are direct products of trans-splicing, and 3 converts into 4 over time:
To account for changes in absorbance, in the RP-HPLC reactions, the peak area of the product is considered to be the total peak areas 3 + 4 + 5. On the other hand for ESI-MS, based on size and composition, we assume that species 1-4 all have similar ionization efficiencies by ESI-MS, whereas 5
is a small molecule with dramatically different ionization properties. Thus the product from ESI-MS reactions is simply 3 + 4. Note that N-intein species (AEY-IntN and IntN) do not separate under any RP-HPLC conditions tested (not shown), thus they were not used for any quantitative analysis. It is noteworthy that the two assay formats gave extremely similar quantitative results ( Figure S13 ).
Our data were fit to the simplified three-state kinetic model shown in Figure 3C and below:
For each reaction, the normalized reaction progress curves for 1, 2, and 3 + 4 (+ 5) were collectively fit to a system of equations that are the analytical solution to the coupled differential rate equations for those species: 
In these equations, p, q, a, and b are algebraic combinations of rate constants k 1 , k 2 , and k 3 that simplify expression of the rate equations. [S/L] is the normalized intensity of the Starting Material / Linear S14
intermediate (1), [B] is the normalized intensity of the Branched Intermediate (2), and [P] is the normalized intensity of the Products (3 + 4 + 5 for RP-HPLC analysis and 3 + 4 for ESI-MS analysis).
The variable t is the reaction time in seconds, and [S/L] 0 can be considered a normalization factor that represents the extent of the reaction (the fraction of starting material that gets converted to product).
The data were fit to equations (1) were averaged. These averages and the standard deviation between these replicates are given in Table 1 of the main text. Finally, the overall rate of splicing (k splice ) was determined by treating product formation, 3 + 4 (+ 5), as a single-step first order reaction and fitting those reaction progress curves to the following equation:
where [P] max is analogous to [S/L] 0 from the previous equations. The average and standard deviation for k splice from three independently fit reactions can be found in Table 1 of the main text.
There were five exceptions to our general curve-fitting protocol. For reactions 4 and 5, branched intermediate resolution was not observed (Figures S11 and S12) . Thus, the reactions were treated as an equilibrium between two states and the curves for 1 and 2 were simultaneously fit to these equations:
For reaction 15, N-extein cleavage caused a re-emergence of starting material 1 ( Figure S12 ), thus the equations for the three-state model could not be readily applied for global fitting. Since BI resolution was extraordinarily slow for this reaction, the reaction was comprised of an initial pre-equilibrium step and a product formation step that were de-coupled. Thus, the data for 1 and 2 from the first 10 minutes of the reaction curve ( Figure S11 ) were fit to the two-state model described by equations (3) to extract k 1 and k 2 . The data for product accumulation (3 + 4) over the course of the entire reaction ( Figure S12 ), were fit to equation (2) to extract k splice , which we assumed to be equal to k 3 . The last two exceptions were reactions 3 and 13, reactions with the C1A mutation. For these reaction, only C-extein cleavage was observed, thus they were treated as a first-order reactions. For reaction 3 the curve for 3 + 4 + CFN(NH 2 ) was fit to equation (2) . For reaction 13, the curve for 3 + 4 was fit to equation (2) . Since reaction 13 was extremely slow and did not plateau after a few days, [P] max was constrained to 0.95, which was the plateau value for the analogous reaction 3.
Double-mutant cycle analysis of the His 125 and Phe +2 interaction
Reactions 1, 12, 14, and 15 collectively make up a double-mutant cycle that probes the importance of Phe +2 in assisting His 125 in intein chemistry. Both His 125 and Phe +2 were shown to be important for catalysis. In reaction 12, the F+2A mutation demonstrates that the steric bulk of Phe +2 is necessary. In reaction 14, the H125N mutation demonstrates that His 125 is a proton donor or acceptor involved in catalysis. Thus, if the effect of the double mutant in reaction 15 is energetically additive of the two individual mutations, the interaction of these two amino acids is not important for protein splicing. This can be expressed mathematically as follows. The change in activation energy upon mutating a system from state a to state b can be calculated by equation (4):
As defined in Figure S14, 
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Phe +2 lost upon double mutation that pertains to BI resolution kinetics can be calculated by applying equation (4) with k 3 for each reaction and equation (5) given below:
This value is +1.07 kcal/mol for the double-mutant cycle presented herein ( Figure S14 ).
Preparation of complexes for NMR spectroscopy 13 C, 15 N-labeled NpuC N137A was expressed analogously to its unlabeled counterpart, except that the expression cultures were grown in minimal M9 medium supplemented with 13 C-glucose and 15 NH 4 Cl as the only carbon and nitrogen sources. After expression, the fusion protein was enriched over a Ni column, and the thiolysis/ligation to the unlabeled CFN(NH 2 ) and CAN(NH 2 ) peptides was carried out as written above. The C-intein constructs were purified and their identities were confirmed by RP-HPLC and ESI-MS ( Figure S7 and Table S2 ).
To prepare the complexes, 1.2 eq of C-intein were added to 10 mL of 35 µM N-intein. The complex was treated with 5 mM TCEP for 10 minute at room temperature then injected on a Superdex 75 16/60 size exclusion column. The complex was eluted over 1.35 CV in NMR buffer (25 mM sodium phosphates, 100 mM NaCl, 1 mM DTT, pH 6.5) and separated from excess C-intein ( Figure S15 ).
Fractions from the size exclusion purification were analyzed by SDS-PAGE on a 12% Bis-Tris gel to determine what region of the major chromatographic peak had a constant N-intein to C-intein ration, and thus 1:1 stoichiometry ( Figure S16 ). These fractions were pooled and concentrated for NMR analysis.
NMR spectroscopy of split intein complexes
Typically 250µM samples were used for all NMR experiments in NMR Buffer. NMR experiments were carried out at either Varian Inova (600MHz) or Bruker (600, 800 or 900MHz) spectrometers equipped with cryogenic probes that can apply pulse field gradients along the z-axis. The data were collected at 25 o C and processed by NMRPipe, 4 and NMRViewJ was used for the analysis. 5 In S17 all constructs the N-intein and N-extein were unlabeled. Only the C-intein was uniformly 15 N, 13 C labeled; the residues comprising the C-terminal extein, CFN(NH 2 ) or CAN(NH 2 ), were chemically synthesized using unlabeled amino-acids and ligated to the C-intein using expressed protein ligation.
Resonance Assignments
The backbone assignments of NpuC N137A with a CFN(NH 2 ) C-extein and in complex with AEY- (6) and can be found in Figure 5C in the main text:
Spin Relaxation Measurements
Relaxation experiments were run at 900 MHz at 25 o C and the analyses were performed using NMRViewJ. Spin-lattice, spin-spin relaxation rates (R 1 , R 2 ) and 15 N-1 H NOE measurements of both complexes were performed by using standard pulse sequences ( Figure S18 ). R 1 and R 2 rates were measured using recycle delays of 1.5 s and the following relaxation delays were used: 
All-atom molecular dynamics simulations
The simulations of DnaE intein from Nostoc punctiforme (NpuDnaE) were carried out using the molecular dynamics (MD) software package AMBER11. 10, 11 The first alternative NMR solution structure within PDB 2KEQ was selected. 12 The selected fused structure was cut between Asn102 and Ile103 to mimic the split form of the intein. The sequence was modified in silico using Chimera 13 to generate constructs of interest: native Npu with the canonical N-extein (A -3 E -2 Y -1 ) and C-extein (C +1 F +2 N +3 ) sequences, a C-extein variant (C +1 A +2 N +3 ), or a D124Y mutation combined with the same C-extein mutation. The C-terminal ends of the C-exteins were charge capped using a special C-terminal residue, NHE, defined in the AMBER ff99sb force field.
14 For each construct, identical all-atom molecular dynamics (MD) simulations were run. Each system was solvated in a box with sides measuring 74 Å, 61|62 Å and 71 Å, charge neutralized with sodium ions, and modeled using the AMBER ff99SB force field. The TIP3P force field was used to model water. 15 We used the SHAKE algorithm to constrain all bonds involving hydrogen atoms. 16 An 8
Å cutoff radius was used for range-limited interactions, utilizing Particle Mesh Ewald electrostatics for long-range interactions. 17 The initial structures were minimized to clear any steric clashes. Periodic boundary with constant volume was used. Harmonic positional restraints of strength 10 kcal/mol/Å 2 S19 were applied to backbone atoms. After the initial minimization step, each system was heated from 0 K to 300 K as a function of time over the course of 50 ps using the Langevin thermostat 18 with a collision frequency of 2 ps while the volume was kept constant. Harmonic positional restraints of strength 2 kcal/mol/Å 2 were used for backbone atoms. Following the heating step, a density equilibration step of 50ps was performed for each system with constant isotropic pressure of 1 atm. Temperature was maintained at 300 K using the Langevin thermostat with 2 ps collision frequency. Harmonic positional restraints of strength 2 kcal/mol/Å 2 were used for backbone atoms. Prior to the production run, a conventional equilibration step of 100 ps was run at 1 atm constant isotropic pressure and 300 K using Figure S4 . Note that for the urea extraction, additional protein could be recovered by re-passing the flow-through over the Ni resin, washing, and eluting as before. Figure S6 . Representative analytical RP-HPLC analysis of Ulp1 cleavage to yield AEY-Int N . The H 6 -SUMO-AEY-NpuN protein, extracted from inclusion bodies, was enriched over Ni-NTA resin and refolded to yield the "Pre-Ulp1" sample. This was treated with Ulp1 to yield the "Post-Ulp1 -14hr" sample. Finally, this sample was passed over a Ni column, and the flow-through and washes with <20 mM imidazole were collected to yield the "Post Ni Column" sample. These samples were analyzed on a C 18 analytical RP-HPLC column at 1 mL/min over a 0-73% B linear gradient in 30 minutes, preceded by a 2 minute isocratic phase in 0% B ( . Note that for the last three chromatographs, corresponding to AEYInt N constructs, peaks around 6.5 and 8 minutes correspond to a DTT monomer and disulfide dimer, respectively. Additionally, the last chromatograph, for AEY-Ssp N , shows that this protein smears on the C 18 column. This was observed irrespective of gradient or sample loading conditions. The sharp peak and the trailing region were found to have the same mass by ESI-MS. 
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Figure S11. Reaction progress curves for splicing assays: the first ten minutes. Error bars represent the standard deviation from three or four independent measurements. The solid lines are reaction progress curves generated by plotting the relevant rate equations (see methods section above) with the average best-fit values for all fitted kinetic parameters (Table 1 , main text).
Figure S12. Reaction progress curves for splicing assays: the entire reaction. Error bars represent the standard deviation from three or four independent measurements. The solid lines are reaction progress curves generated by plotting the relevant rate equations (see methods section above) with the average best-fit values for all fitted kinetic parameters (Table 1 , main text). Note that for reaction 13, the lines for species 1 (black) and 2 (purple) are not fitted curves (see methods section above for details). . SDS-PAGE analysis of complexes for NMR. Eight fractions, equally spaced throughout the entire major size-exclusion peak shown in Figure S15 , were analyzed by SDS-PAGE. For the CFN(NH 2 ) complex, fractions 2-7 had a roughly constant ratio of N-to C-intein (black and magenta, respectively). For the CAN(NH 2 ) complex, fractions 1-6 had a roughly constant ratio of N-to C-intein. These fractions were pooled for NMR analysis. 
